| 0000-00-00 |
|
|
|
External link to document |
| 2018-07-02 |
10 |
Redacted Document |
assignment of the ’122 patent.
62. U.S. Patent No. 7,449,184 (“the ’184 patent”), titled “Fixed…with Perjeta
60. U.S. Patent Nos. 7,501,122, 7,449,184, and 8,691,232 claim novel therapies… INFRINGEMENT OF U.S. PATENT NO. 7,449,184
190. Plaintiffs incorporate…: U.S. Patent No. 6,331,415, U.S. Patent No. 7,923,221, U.S. Patent No.
6,407,213, U.S. Patent No. 7,…, U.S. Patent No. 7,892,549, U.S. Patent No. 6,627,196,
U.S. Patent No. 7,371,379, U.S. Patent No. 6, |
External link to document |
| 2019-06-14 |
256 |
Opinion - Memorandum Opinion |
quot;the '066 patent"); 8,574,869 ("the '869 patent"); 8,512,983
("the '…of terms set forth in U.S. Patent Nos. 7,993,834 ("the '834
patent"); 8,076,066 ("…#x27;983 patent"); and 7,390,660 ("the '660 patent"). D.I. 60; D.I. 121. 1
…quot;It is a bedrock principle of patent law that the claims of a patent define the
invention to which …clauses of both patents were added by Genentech in response to same objection by
the patent examiner. Compare |
External link to document |
| 2019-07-22 |
315 |
Opinion - Memorandum Opinion |
. 6,620,918; 8,512,983;
8,574,869; and 9,714,293.
2
specific… in the three Dosing Patents: U.S. Patent Nos.
6,627,196 (the "#196 patent"), 7,371,379 (the… "#379 patent") and 10,160,811 (the
"#811 patent"). All three patents relate to methods… U.S. Patent Nos. 7,993,834 and
8,076,066.
4 The Manufacturing Patents at issue are U.S. Patent Nos. …litigating ten patents which cover: (i) the
trastuzumab antibody itself (the Composition Patent)2; (ii) techniques |
External link to document |
| 2019-07-26 |
330 |
Stipulation to EXTEND Time |
Exchange Opening Expert Reports for U.S. Patent Nos. 8,512,983 and 9,714,293 to August 2, 2019 - filed … 2018
7 July 2020
1:18-cv-00924
830 Patent
Plaintiff
District Court, D. Delaware |
External link to document |
